Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine phosphate efficacy study in hospitalized adults with COVID-19
ChiCTR2000029609Phase 4Not yet recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of chloroquine, lopinavir and ritonavir in coronavirus disease 2019 (COVID-19) (5 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Virus nucleic acid negative-transforming time. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
chloroquinelopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000029609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029609.